Publicacións nas que colabora con AMADO ANDRÉS BELMONTE (44)

2024

  1. Prophylactic Anticoagulation Reduces the Risk of Kidney Graft Venous Thrombosis in Recipients from Uncontrolled Donation after Circulatory Death Donors with High Renal Resistive Index

    Transplantation Direct, Vol. 10, Núm. 6, pp. E1649

2023

  1. Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5-adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients

    Transplantation Direct, Vol. 9, Núm. 10, pp. E1536

2022

  1. Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods

    Mycoses, Vol. 65, Núm. 5, pp. 517-525

  2. Short series regarding uncontrolled donor after cardiac death: A call for caution

    Clinical Transplantation

  3. The Immunobiogram, a novel in vitro diagnostic test to measure the pharmacodynamic response to immunosuppressive therapy in kidney transplant patients

    Transplant Immunology, Vol. 75

2020

  1. A New Clinical and Immunovirological Score for Predicting the Risk of Late Severe Infection in Solid Organ Transplant Recipients: The CLIV Score

    The Journal of infectious diseases, Vol. 222, Núm. 3, pp. 479-487

  2. COVID-19 in solid organ transplant recipients: A single-center case series from Spain

    American Journal of Transplantation, Vol. 20, Núm. 7, pp. 1849-1858

  3. Early Posttransplant Mobilization of Monocytic Myeloid-derived Suppressor Cell Correlates With Increase in Soluble Immunosuppressive Factors and Predicts Cancer in Kidney Recipients

    Transplantation, Vol. 104, Núm. 12, pp. 2599-2608

  4. Kidney transplantation in the extremely elderly from extremely aged deceased donors: A kidney for each age

    Nephrology Dialysis Transplantation, Vol. 35, Núm. 4, pp. 687-696

2017

  1. The presence of pretransplant antiphospholipid antibodies iga anti-b-2-glycoprotein i as a predictor of graft thrombosis after renal transplantation

    Transplantation, Vol. 101, Núm. 3, pp. 597-607

2016

  1. Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study)

    Nefrologia, Vol. 36, Núm. 3, pp. 255-267

2015

  1. Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease

    Journal of Infection, Vol. 71, Núm. 5, pp. 561-570

  2. Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients

    Transplant Infectious Disease, Vol. 17, Núm. 5, pp. 637-646

  3. Uncontrolled non-heartbeating donors (types i-II) with normothermic recirculation vs. heartbeating donors: Evaluation of functional results and survival

    Actas Urologicas Espanolas, Vol. 39, Núm. 7, pp. 429-434

2014

  1. Spanish consensus document for acceptance and rejection of kidneys from expanded criteria donors

    Clinical Transplantation, Vol. 28, Núm. 10, pp. 1155-1166

2013

  1. Donation after cardiac death: Results of the SUMMA 112 - Hospital 12 de Octubre Program

    Clinical Transplantation, Vol. 27, Núm. 2, pp. 283-288

  2. Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation

    Clinical Microbiology and Infection, Vol. 19, Núm. 12, pp. 1132-1139

  3. High incidence of delayed graft function in HIV-infected kidney transplant recipients

    Transplant International, Vol. 26, Núm. 9, pp. 893-902

  4. The impact of darbepoietin alfa in early post-transplant anaemia management: Retrospective exploratory study

    Nefrologia, Vol. 33, Núm. 1, pp. 107-115

2011

  1. Donantes tipo III de maastricht

    Medicina Intensiva